Viemed Healthcare Valuation

VMD Stock  USD 8.36  0.08  0.97%   
At this time, the company appears to be undervalued. Viemed Healthcare has a current Real Value of $9.77 per share. The regular price of the company is $8.36. Our model measures the value of Viemed Healthcare from inspecting the company fundamentals such as Return On Equity of 0.11, operating margin of 0.1 %, and Shares Outstanding of 38.02 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Viemed Healthcare's valuation include:
Price Book
2.3589
Enterprise Value
328.7 M
Enterprise Value Ebitda
6.7868
Price Sales
1.2604
Forward PE
17.1821
Undervalued
Today
8.36
Please note that Viemed Healthcare's price fluctuation is not too volatile at this time. Calculation of the real value of Viemed Healthcare is based on 3 months time horizon. Increasing Viemed Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Viemed stock is determined by what a typical buyer is willing to pay for full or partial control of Viemed Healthcare. Since Viemed Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Viemed Stock. However, Viemed Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  8.36 Real  9.77 Target  13.0 Hype  8.48
The real value of Viemed Stock, also known as its intrinsic value, is the underlying worth of Viemed Healthcare Company, which is reflected in its stock price. It is based on Viemed Healthcare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Viemed Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
9.77
Real Value
11.81
Upside
Estimating the potential upside or downside of Viemed Healthcare helps investors to forecast how Viemed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Viemed Healthcare more accurately as focusing exclusively on Viemed Healthcare's fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
0.070.090.11
Details
Hype
Prediction
LowEstimatedHigh
6.448.4810.52
Details
3 Analysts
Consensus
LowTarget PriceHigh
11.8313.0014.43
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Viemed Healthcare's intrinsic value based on its ongoing forecasts of Viemed Healthcare's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Viemed Healthcare's closest peers. If more than one evaluation category is relevant for Viemed Healthcare we suggest using both methods to arrive at a better estimate.

Viemed Healthcare Cash

14.47 Million

Viemed Revenue by Product

Viemed Healthcare Total Value Analysis

Viemed Healthcare is at this time expected to have company total value of 328.74 M with market capitalization of 321.15 M, debt of 6.87 M, and cash on hands of 21.92 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Viemed Healthcare fundamentals before making security assessment based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
328.74 M
321.15 M
6.87 M
21.92 M

Viemed Healthcare Investor Information

About 14.0% of the company outstanding shares are owned by insiders. The book value of Viemed Healthcare was at this time reported as 3.51. The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Viemed Healthcare's historical financial statements, Viemed Healthcare may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Profit Margin0.180.0918
Way Up
Slightly volatile
Total Cash From Operating Activities24.7 M45 M
Way Down
Slightly volatile
Operating Income13.3 M20.6 M
Way Down
Slightly volatile

Viemed Healthcare Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Viemed Healthcare has an asset utilization ratio of 126.65 percent. This indicates that the Company is making $1.27 for each dollar of assets. An increasing asset utilization means that Viemed Healthcare is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid
 
Interest Hikes

Viemed Healthcare Profitability Analysis

Based on the measurements of profitability obtained from Viemed Healthcare's financial statements, Viemed Healthcare's profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Viemed Healthcare's ability to earn profits and add value for shareholders.
 
Net Income  
First Reported
2016-09-30
Previous Quarter
3.2 M
Current Value
3.5 M
Quarterly Volatility
M
 
Covid
 
Interest Hikes
At present, Viemed Healthcare's Pretax Profit Margin is projected to slightly decrease based on the last few years of reporting. The current year's Operating Profit Margin is expected to grow to 0.18, whereas Net Profit Margin is forecasted to decline to 0.05.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.750.68
Significantly Up
Slightly volatile
Net Profit Margin0.05490.0578
Notably Down
Slightly volatile
Operating Profit Margin0.180.0918
Way Up
Slightly volatile
Pretax Profit Margin0.170.0829
Way Up
Slightly volatile
Return On Assets0.06950.0732
Notably Down
Slightly volatile
Return On Equity0.09370.0986
Notably Down
Slightly volatile
For Viemed Healthcare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Viemed Healthcare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Viemed Healthcare utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Viemed Healthcare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Viemed Healthcare over time as well as its relative position and ranking within its peers.

Viemed Healthcare Earnings per Share Projection vs Actual

The next projected EPS of Viemed Healthcare is estimated to be 0.09 with future projections ranging from a low of 0.07 to a high of 0.11. Viemed Healthcare's most recent 12-month trailing earnings per share (EPS TTM) is at 0.34. Please be aware that the consensus of earnings estimates for Viemed Healthcare is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Viemed Healthcare is projected to generate 0.09 in earnings per share on the 31st of March 2026. Viemed Healthcare earnings estimates show analyst consensus about projected Viemed Healthcare EPS (Earning Per Share). It derives the highest and the lowest estimates based on Viemed Healthcare's historical volatility. Many public companies, such as Viemed Healthcare, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Viemed Healthcare Earnings Estimation Breakdown

The calculation of Viemed Healthcare's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Viemed Healthcare is estimated to be 0.09 with the future projection ranging from a low of 0.07 to a high of 0.11. Please be aware that this consensus of annual earnings estimates for Viemed Healthcare is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
0.07
Lowest
Expected EPS
0.09
0.11
Highest

Viemed Healthcare Earnings Projection Consensus

Suppose the current estimates of Viemed Healthcare's value are higher than the current market price of the Viemed Healthcare stock. In this case, investors may conclude that Viemed Healthcare is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Viemed Healthcare's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2026Current EPS (TTM)
269.86%
0.0
0.09
0.34

Viemed Healthcare Ownership Allocation

Viemed Healthcare shows a total of 38.02 Million outstanding shares. Over half of Viemed Healthcare's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Viemed Healthcare Profitability Analysis

The company reported the last year's revenue of 224.26 M. Total Income to common stockholders was 11.41 M with profit before taxes, overhead, and interest of 147.49 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Viemed Healthcare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Viemed Healthcare and how it compares across the competition.

About Viemed Healthcare Valuation

The stock valuation mechanism determines Viemed Healthcare's current worth on a weekly basis. Our valuation model uses a comparative analysis of Viemed Healthcare. We calculate exposure to Viemed Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Viemed Healthcare's related companies.
Last ReportedProjected for Next Year
Gross Profit153.2 M160.8 M
Pretax Profit Margin 0.08  0.17 
Operating Profit Margin 0.09  0.18 
Net Profit Margin 0.06  0.05 
Gross Profit Margin 0.68  0.75 

Viemed Healthcare Quarterly Retained Earnings

97.25 Million

Viemed Healthcare Growth Indicators

Investing in growth stocks can be very risky. If the company such as Viemed Healthcare does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding40.8 M
Quarterly Earnings Growth Y O Y-0.098
Forward Price Earnings17.1821

Viemed Healthcare Current Valuation Indicators

Valuation refers to the process of determining the present value of Viemed Healthcare and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Viemed we look at many different elements of the entity such as Viemed's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Viemed Healthcare, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Viemed Healthcare's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Viemed Healthcare's worth.

Complementary Tools for Viemed Stock analysis

When running Viemed Healthcare's price analysis, check to measure Viemed Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viemed Healthcare is operating at the current time. Most of Viemed Healthcare's value examination focuses on studying past and present price action to predict the probability of Viemed Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viemed Healthcare's price. Additionally, you may evaluate how the addition of Viemed Healthcare to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities